Skip to content

Liraglutide studies: 1,219 papers with results

Page 10 of 25

  1. Approved weight loss drugs for obesity with a thorough emphasis on GLP-1 agonist medications: A systematic review.

    Gunasekaran P · Disease-a-month : DM · 2026

    Systematic review · 33 results

  2. Comparison of pharmacotherapies for obesity with sleeve gastrectomy: a network meta-analysis and systematic review.

    Omeh Z · Expert review of endocrinology & metabolism · 2026

    Systematic review · 5 results

  3. Effect of Hypoglycemic Drugs on Patients with Heart Failure with or without T2DM: A Bayesian Network Meta-analysis.

    Zhang Z · Reviews in cardiovascular medicine · 2025

    Systematic review · 2 results

  4. Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH.

    Majzoub AM · Alimentary pharmacology & therapeutics · 2021

    Systematic review · 4 results

  5. Meta-analysis of randomized controlled trials for the development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) guidelines on multimodal strategies for the surgical treatment of obesity.

    De Luca M · Diabetes, obesity & metabolism · 2025

    Systematic review · 6 results

  6. Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic Review.

    Meshkat S · Brain and behavior · 2025

    Systematic review · 4 results

  7. The concentration-dependent protective effects by new generation hypoglycemic agents on delirium, depression, dementia and coma: evidence from a network meta-analysis.

    Tseng PT · Journal of the Royal Society of Medicine · 2026

    Systematic review · 5 results

  8. Effects of different hypoglycaemic drugs on beta-cell function in type 2 diabetes mellitus: a systematic review and network meta-analysis.

    Guo Z · European journal of medical research · 2025

    Systematic review · 2 results

  9. Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.

    Chiappa GR · Diabetes, obesity & metabolism · 2026

    Systematic review · 9 results

  10. Preferred Glucagon-like Peptide-1 Receptor Agonists in Adults With Type 2 Diabetes and Established Cardiovascular Disease or High Cardiovascular Risk: A Network Meta-analysis of Randomized Trials.

    Abomohsen M · Canadian journal of diabetes · 2026

    Systematic review · 13 results

  11. Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials.

    Zhang YS · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018

    Systematic review · 4 results

  12. Cardiovascular outcomes of liraglutide in patients with type 2 diabetes: A systematic review and meta-analysis.

    Duan CM · Medicine · 2019

    Systematic review · 7 results

  13. Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials.

    Zhao X · BMC endocrine disorders · 2019

    Systematic review · 6 results

  14. Liraglutide for adults living with obesity.

    Meza N · The Cochrane database of systematic reviews · 2025

    Systematic review · 18 results

  15. Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials.

    Moon S · Endocrinology and metabolism (Seoul, Korea) · 2021

    Systematic review · 7 results

  16. Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials.

    Lin Q · Expert review of clinical pharmacology · 2022

    Systematic review · 4 results

  17. Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients.

    Ayers D · Current medical research and opinion · 2017

    Systematic review · 5 results

  18. Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs.

    Singh AK · Expert review of clinical pharmacology · 2020

    Systematic review · 1 result

  19. Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme.

    Zinman B · Diabetes, obesity & metabolism · 2012

    Systematic review · 3 results

  20. Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme.

    Montanya E · Diabetes, obesity & metabolism · 2016

    Systematic review · 2 results

  21. Impact of diabetes duration on achieved reductions in glycated haemoglobin, fasting plasma glucose and body weight with liraglutide treatment for up to 28 weeks: a meta-analysis of seven phase III trials.

    Seufert J · Diabetes, obesity & metabolism · 2016

    Systematic review · 5 results

  22. Liraglutide's Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis.

    Alsanea S · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2024

    Systematic review · 7 results

  23. Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.

    Armstrong MJ · Alimentary pharmacology & therapeutics · 2013

    Systematic review · 8 results

  24. Meta-analysis of seven heterogeneous studies on liraglutide add-on therapy in patients with type 2 diabetes mellitus treated with insulin.

    Shibuki K · Diabetes & metabolic syndrome · 2022

    Systematic review · 3 results

  25. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.

    Hemmingsen B · The Cochrane database of systematic reviews · 2017

    Systematic review · 9 results

  26. Effects of liraglutide on body composition in people living with obesity or overweight: A systematic review.

    Schmidt PHS · Obesity research & clinical practice · 2025

    Systematic review · 4 results

  27. Pharmacologic therapy to induce weight loss in women who have obesity/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis.

    Wang FF · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2018

    Systematic review · 3 results

  28. The Influence of Liraglutide for Heart Failure: A Meta-Analysis of Randomized Controlled Trials.

    Zhang Y · The heart surgery forum · 2019

    Systematic review · 8 results

  29. Comparative effectiveness of exenatide once-weekly versus liraglutide in routine clinical practice: A retrospective multicentre study and meta-analysis of observational studies.

    Fadini GP · Diabetes, obesity & metabolism · 2019

    Systematic review · 6 results

  30. Long-term administration of liraglutide for weight management in pediatric patients under 18 years: evidence from 7 randomized controlled trials.

    Dong J · Pediatric research · 2026

    Systematic review · 9 results

  31. Analysis of the effect of liraglutide on glycemic variability in patients with type 2 diabetes.

    Xing Y · Endocrine journal · 2020

    Systematic review · 4 results

  32. Efficacy and safety of liraglutide in non-alcoholic fatty liver disease with or without type 2 diabetes: A systematic review and meta-analysis.

    Kong W · Diabetes, obesity & metabolism · 2026

    Systematic review · 9 results

  33. Impact of liraglutide on albumin-to-creatinine ratio in type 2 diabetes mellitus: a meta-analysis.

    Wang F · European journal of medical research · 2025

    Systematic review · 11 results

  34. Liraglutide monotherapy and add on therapy on obese women with polycystic ovarian syndromes: a systematic review and meta-analysis.

    Tian D · Minerva medica · 2022

    Systematic review · 6 results

  35. Weight Loss Medications for Adult Patients With Obesity and Binge Eating-A Systematic Review and Meta-analysis.

    Violante-Cumpa JR · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026

    Systematic review · 3 results

  36. Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials.

    Shomali ME · Diabetic medicine : a journal of the British Diabetic Association · 2017

    Systematic review · 9 results

  37. A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries.

    Niafar M · Archives of gynecology and obstetrics · 2016

    Systematic review · 6 results

  38. Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis.

    Vinciguerra F · Obesity surgery · 2024

    Systematic review · 6 results

  39. Efficacy of GLP-1rA, liraglutide, in plaque psoriasis treatment with type 2 diabetes: a systematic review and meta-analysis of prospective cohort and before-after studies.

    Chang G · The Journal of dermatological treatment · 2022

    Systematic review · 5 results

  40. Pharmacological and non-pharmacological strategies for obese women with subfertility.

    Taghavi SA · The Cochrane database of systematic reviews · 2021

    Systematic review · 5 results

  41. The role of glucagon-like peptide 1 receptor agonists for weight control in individuals with acquired hypothalamic obesity-A systematic review.

    Ng VWW · Clinical obesity · 2024

    Systematic review · 6 results

  42. Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence.

    Muller DRP · Frontiers in endocrinology · 2023

    Systematic review · 5 results

  43. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.

    Htike ZZ · Diabetes, obesity & metabolism · 2017

    Systematic review · 10 results

  44. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.

    Tsapas A · Annals of internal medicine · 2020

    Systematic review · 6 results

  45. Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis.

    Sun F · Diabetes research and clinical practice · 2015

    Systematic review · 6 results

  46. Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.

    Domecq JP · The Journal of clinical endocrinology and metabolism · 2015

    Systematic review · 1 result

  47. Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.

    Sun F · Clinical therapeutics · 2015

    Systematic review · 5 results

  48. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.

    Wang B · Diabetes, obesity & metabolism · 2013

    Systematic review · 4 results

  49. Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials.

    Su B · Endocrine · 2015

    Systematic review · 1 result

  50. Anti-diabetic drugs and weight loss in patients with type 2 diabetes.

    Lazzaroni E · Pharmacological research · 2021

    Systematic review · 3 results

How PepBank reports evidence